Lacey, WA – December 19, 2005 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, has announced the launch of UniBEX™, the company’s all-natural cardiovascular health product. UniBEX™, comprising patented bio-active compounds extracted from the bamboo leaf, was featured at the 9th Annual SupplySide West International Trade Show and Conference that took place in Las Vegas November 9 – 11.
Healthy blood circulation and optimum cardiovascular health are of major concern in today’s global society, with 50,000 deaths per year in the U.S. attributed to cardiovascular disease.
“Unigen has spent the past five years developing UniBEX™ for its novel potential to address overall cardiovascular health and antioxidant activity, including healthy blood circulation and blood lipid profiles,” said Regan Miles, Unigen’s President and Chief Operating Officer. “With SupplySide West drawing more than 6,100 executives who share a passion for novel concepts in health and wellness, Unigen was excited to launch this new product in the company of fellow innovators.”
UniBEX™ was featured in a SupplySide West VendorWorks Presentation made by Marcus Laux, a licensed naturopathic physician and Chairman of Unigen’s Scientific Advisory Board, who discussed the cardiovascular health benefits of UniBEX™ as portrayed in DNA micro-array tests and human clinical research carried out by Unigen.
Scientists at Unigen used the company’s platform technologies, PhytoLogix™ and GenoActive™, to identify and standardize the bio-actives found in UniBEX™, derived from bamboo, an ingredient safely used in Asia for thousands of years in traditional medicine and food products.
# # #
About Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. (www.UnigenPharma.com) is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen and sister company Aloecorp, Inc. each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary, patented raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
Regan Miles, President & Chief Operating Officer